Neue Daten bestätigen beständige Wirksamkeit und unbedenkliches ...
Support Safety and Efficacy of RESOLOR(R) for Treatment of Chronic Constipation.Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation
chemie.pr-rss.com
29.05.2008 18:40:11
Movetis NV: Turnhout, Belgium (ots/PRNewswire) - Movetis today announced that the European Medicines Agency (EMeA) has accepted the Marketing Authorization Application (MAA) submission for RESOLOR(R) (prucalopride) as a treatment for chronic constipation in ...
Lesen Sie hier weiter... |
Drucken |
PDF
Support Safety and Efficacy of RESOLOR(R) for Treatment of Chronic Constipation.Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation
36 Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation Effectiveness and Safety of RESOLOR(R) for Patients With Chronic Constipation
Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation and Safety of RESOLOR(R) for Patients With Chronic.Constipation
Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation Effectiveness and Safety of RESOLOR(R) for Patients With Chronic Constipation
Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation